Skip to main content

Table 2 Comparison of clinical features of patients in the restenosis and non-restenosis groups

From: Diagnostic value of microRNA-143 in predicting in-stent restenosis for patients with lower extremity arterial occlusive disease

Feature Restenosis group (n = 74) Non-restenosis group (n = 91) P
Age (years) 65.4 ± 8.6 64.7 ± 8.0 0.583
Male, n (%) 52 (70.2) 60 (65.9) 0.553
BMI (kg/m2) 24.8 ± 3.6 24.1 ± 3.2 0.184
Hypertension, n (%) 19 (25.7) 22 (24.2) 0.825
Hyperlipidemia, n (%) 15 (20.3) 17 (18.7) 0.797
Renal dysfunction, n (%) 10 (13.5) 11 (12.1) 0.785
Diabetes, n (%) 21 (28.4) 6 (6.6) <0.001
Smoking, n (%) 59 (79.7) 27 (29.7) <0.001
Drinking, n (%) 33 (44.6) 40 (44.0) 0.935
SBP (mmHg) 137.8 ± 22.3 133.6 ± 21.5 0.221
DBP (mmHg) 73.4 ± 9.8 72.6 ± 7.7 0.558
HDL-C (mmol/L) 1.1 ± 0.3 1.2 ± 0.3 0.177
LDL-C (mmol/L) 3.0 ± 0.5 2.5 ± 0.3 <0.001
Blood sugar, (mmol/L) 6.3 ± 2.0 5.4 ± 1.8 <0.001
Stent mean diameter (mm) 7.4 ± 1.0 6.6 ± 1.0 <0.001
  1. BMI body mass index; SBP systolic blood pressure; DBP diastolic blood pressure; HDL-C high-density lipoprotein cholesterol; LDL-C low-density lipoprotein cholesterol